Differential beta-adrenoblocker therapy in chronic heart failure: the role of age, gender, and co-morbidity
Aim. To investigate differential beta-adrenoblocker (BAB) therapy, based on clinical and demographic characteristics of the patients, as a method to optimise the management of chronic heart failure (CHF).Material and methods. The study included 90 patients: 50 men (55,6%) and 40 women (44,4%) of mea...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Russo |
| Опубликовано: |
«SILICEA-POLIGRAF» LLC
2009-10-01
|
| Серии: | Кардиоваскулярная терапия и профилактика |
| Предметы: | |
| Online-ссылка: | https://cardiovascular.elpub.ru/jour/article/view/1855 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|